We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Jacinda Ardern has handed the reins over to her deputy while she takes six weeks of leave.
The Chancellor has called for new financial partnerships to open up markets beyond the EU.
The haul is part of Operation Thunderstorm which ran throughout May and involved 1,974 seizures including 43 tonnes of wild meat.